Bruker Cellular Analysis is uniquely enabling the exploration of the
phenome and mastery of single cells for all labs & scientists
through a simple and accessible workflow.
for Biotherapeutics
Maximize Success with Function-First Screening, Host Diversification, and Automated 1-Day Workflow Even for Challenging Targets
Applications across all stages of discovery & development
Manage your discovery & development leveraging the phenome
Accelerate your product development by analyzing the phenotype and genotype of single cells or clones and generating insights by rapidly screening 1000s of cells at once.
Capture highly multiplexed cytokine, chemokine, and phosphoprotein signatures from single cells to predict disease progression, treatment resistance, and therapeutic efficacy.
See how top researchers use our technology to shape the next wave of scientific innovation.
"With the Beacon Platform, we are able to determine the phenotypic and functional characteristics of cells in real time, isolate specific cells of interest, and link the genomic profiles of these same cells using downstream assays."
"With the Beacon, (Mycenax) offers the next-generation of CLD platform with shorter timeline and more high-productivity clones."
"The main reason why we employ the Beacon system here at Abveris is to enable deep characterization of single B cells in multiple sequential assays. Its design allows for precise control of the movement of cells, leaving you with the ultimate flexibility in assay design and, as a result, a higher screening resolution."